Every 10-Q that Astrotech Corp (ASTC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow ASTC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ASTC filings page.
Astrotech Corporation filed an amended quarterly report to correct the disclosed number of common shares issuable upon conversion of its Series D convertible preferred stock, now stating that 280,898 preferred shares convert on a one-for-thirty basis into approximately 9,363 common shares.
For the quarter ended March 31, 2026, revenue was $343 thousand, down from $534 thousand a year earlier, and gross margin declined to 20% as some high-cost consumables were sold below cost. Operating expenses were $3,520 thousand, resulting in a net loss of $3,768 thousand, and a nine-month net loss of $11,161 thousand on $787 thousand of revenue.
As of March 31, 2026, Astrotech held $2,679 thousand in cash and $3,903 thousand in short-term investments, with working capital of about $9.5 million. Management expects these resources, operating cash flows, and capital-raising activities to fund operations for at least 12 months and has a $30 million shelf registration (subject to a Baby Shelf Limitation) to preserve funding flexibility.
Astrotech Corporation reports continued operating losses and shrinking cash as it invests in commercialization of its mass spectrometry platforms. For the three months ended March 31, 2026, revenue was $343,000, down from $534,000 a year earlier, with gross margin falling to 20% from 44% as some older consumables were sold below cost.
Operating expenses declined 14.2% to $3.5 million, but the company still posted a net loss of $3.8 million for the quarter and $11.2 million for the nine‑month period. Cash and cash equivalents were $2.7 million and short‑term investments $3.9 million, supporting working capital of about $9.5 million. Management believes these resources, plus operating cash flows and potential capital‑raising, will fund operations for at least the next 12 months, though substantial additional capital is expected to be needed for longer‑term growth.
Astrotech Corporation reported another loss-making quarter while maintaining a solid cash position. For the three months ended December 31, 2025, revenue fell to $148,000 from $261,000, as lower instrument and grant sales outweighed stronger consumables demand. Net loss was $3.9 million, slightly better than the prior year’s $4.0 million, driven mainly by lower operating expenses.
For the six-month period, revenue rose to $445,000 from $295,000, but the company still recorded a $7.4 million net loss. Operating cash outflow was $7.5 million, largely offset by $7.5 million of proceeds from short‑term investments, keeping cash at $3.1 million and short‑term investments at $7.0 million. Working capital stood at about $12.5 million, and management believes existing resources, together with potential equity offerings, can fund operations for at least the next 12 months.
The company continues to invest in commercializing its mass spectrometry platforms across security (TRACER 1000), agriculture (AgLAB 1000-D2), industrial process control (Pro-Control 1000-D2), and new environmental testing products under its EN-SCAN subsidiary. An S‑3 shelf registration was declared effective on January 30, 2026, but no securities have been sold under it yet. As of February 12, 2026, Astrotech had 1,758,953 common shares outstanding.
Astrotech Corporation (ASTC) reported Q1 FY2025 results. Revenue was $297 thousand versus $34 thousand a year ago, with gross margin improving to 63% from 26%. The company recorded a net loss of $3.465 million (basic and diluted net loss per share $2.07), reflecting continued investment in operations.
Operating cash flow was $(3.936) million. Cash and cash equivalents were $2.646 million, and short‑term investments were $11.290 million, supporting working capital of approximately $16.3 million as of September 30, 2025. Total assets were $23.240 million and stockholders’ equity was $19.087 million.
Revenue included U.S. sales of $256 thousand and foreign sales of $41 thousand. Three customers comprised substantially all revenue for the quarter. As of November 11, 2025, common shares outstanding were 1,758,953. The company also noted an 89‑month lease for its Austin Metric Facility with total base rent obligations of about $3.0 million, less a $317.3 thousand tenant allowance.